CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 111 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,312,000 | -4.0% | 67,993 | -41.3% | 0.19% | +18.5% |
Q2 2017 | $1,367,000 | -53.7% | 115,811 | -57.0% | 0.16% | -43.9% |
Q1 2017 | $2,951,000 | -10.9% | 269,227 | -41.0% | 0.29% | +4.3% |
Q4 2016 | $3,313,000 | +31.2% | 456,389 | +17.4% | 0.28% | +14.9% |
Q3 2016 | $2,526,000 | +49.2% | 388,582 | +25.3% | 0.24% | +3.4% |
Q2 2016 | $1,693,000 | +28.3% | 310,029 | +9.9% | 0.23% | +28.7% |
Q1 2016 | $1,320,000 | -15.0% | 282,030 | -9.5% | 0.18% | -8.1% |
Q4 2015 | $1,553,000 | +50.5% | 311,759 | +13.6% | 0.20% | +20.9% |
Q3 2015 | $1,032,000 | +3.3% | 274,419 | +65.2% | 0.16% | 0.0% |
Q2 2015 | $999,000 | +23.0% | 166,150 | +14.6% | 0.16% | +55.2% |
Q1 2015 | $812,000 | +108.7% | 144,950 | +11.8% | 0.10% | +90.9% |
Q4 2014 | $389,000 | +213.7% | 129,692 | +180.1% | 0.06% | +175.0% |
Q3 2014 | $124,000 | -42.1% | 46,300 | -39.4% | 0.02% | -50.0% |
Q2 2014 | $214,000 | +103.8% | 76,400 | +217.0% | 0.04% | +29.0% |
Q1 2014 | $105,000 | +78.0% | 24,100 | +31.0% | 0.03% | +29.2% |
Q4 2013 | $59,000 | – | 18,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |